Adalimumab Effectively Decreases Inflammation Downstream of TNFα Signaling in Synoviocytes from Extended Oligoarticular Juvenile Idiopathic Arthritis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Adalimumab Effectively Decreases Inflammation Downstream of TNFα Signaling in Synoviocytes from Extended Oligoarticular Juvenile Idiopathic Arthritis ; volume:11 ; number:1 ; day:9 ; month:12 ; year:2023 ; pages:143-155 ; date:2.2024
Rheumatology and therapy ; 11, Heft 1 (9.12.2023), 143-155, 2.2024
- Urheber
-
Simonds, Megan M.
Freer, Samuel T.
Al-Jaberi, Lina
Brescia, AnneMarie C.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40744-023-00628-z
- URN
-
urn:nbn:de:101:1-2024033111045085423856
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Simonds, Megan M.
- Freer, Samuel T.
- Al-Jaberi, Lina
- Brescia, AnneMarie C.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Adalimumab regulates intracellular TNFα production in patients with rheumatoid arthritis
Dynamische Interaktion zwischen Leukozyten und Endothelzellen unter dem Einfluss von TNFα und Adalimumab
Humira (Adalimumab) : Adalimumab in der Therapie der Psoriasis
Autologous chondrocyte implantation in osteoarthritic surroundings : TNFα and its inhibition by Adalimumab in a knee-specific bioreactor
Tumor necrosis factor-alpha (TNF-α) enhances functional thermal and chemical responses of TRP cation channels in human synoviocytes
Adalimumab and anti-adalimumab LISA-TRACKER immunoassays performance criteria for therapeutic drug monitoring of adalimumab-amgen biosimilar (ABP501)
AVT02: An Adalimumab Biosimilar
Downstream
CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes
Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab
Epigenetic analysis in rheumatoid arthritis synoviocytes
Efficacy of adalimumab in sarcoidosis
Adalimumab regulates intracellular TNFα production in patients with rheumatoid arthritis
Dynamische Interaktion zwischen Leukozyten und Endothelzellen unter dem Einfluss von TNFα und Adalimumab
Humira (Adalimumab) : Adalimumab in der Therapie der Psoriasis
Autologous chondrocyte implantation in osteoarthritic surroundings : TNFα and its inhibition by Adalimumab in a knee-specific bioreactor
Tumor necrosis factor-alpha (TNF-α) enhances functional thermal and chemical responses of TRP cation channels in human synoviocytes
Adalimumab and anti-adalimumab LISA-TRACKER immunoassays performance criteria for therapeutic drug monitoring of adalimumab-amgen biosimilar (ABP501)
AVT02: An Adalimumab Biosimilar
Downstream
CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes
Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab
Epigenetic analysis in rheumatoid arthritis synoviocytes
Efficacy of adalimumab in sarcoidosis
Adalimumab regulates intracellular TNFα production in patients with rheumatoid arthritis
Dynamische Interaktion zwischen Leukozyten und Endothelzellen unter dem Einfluss von TNFα und Adalimumab
Humira (Adalimumab) : Adalimumab in der Therapie der Psoriasis
Autologous chondrocyte implantation in osteoarthritic surroundings : TNFα and its inhibition by Adalimumab in a knee-specific bioreactor
Tumor necrosis factor-alpha (TNF-α) enhances functional thermal and chemical responses of TRP cation channels in human synoviocytes
Adalimumab and anti-adalimumab LISA-TRACKER immunoassays performance criteria for therapeutic drug monitoring of adalimumab-amgen biosimilar (ABP501)
AVT02: An Adalimumab Biosimilar
Downstream
CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes
Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab
Epigenetic analysis in rheumatoid arthritis synoviocytes